These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 34466409)

  • 1. Molecular Targets of Ferroptosis in Hepatocellular Carcinoma.
    Liao H; Shi J; Wen K; Lin J; Liu Q; Shi B; Yan Y; Xiao Z
    J Hepatocell Carcinoma; 2021; 8():985-996. PubMed ID: 34466409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ferroptosis: From Basic Research to Clinical Therapeutics in Hepatocellular Carcinoma.
    Huang Z; Xia H; Cui Y; Yam JWP; Xu Y
    J Clin Transl Hepatol; 2023 Feb; 11(1):207-218. PubMed ID: 36406319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ferroptosis: a new hunter of hepatocellular carcinoma.
    Jiang Y; Yu Y; Pan Z; Glandorff C; Sun M
    Cell Death Discov; 2024 Mar; 10(1):136. PubMed ID: 38480712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perspectives and mechanisms for targeting ferroptosis in the treatment of hepatocellular carcinoma.
    Li L; Wang X; Xu H; Liu X; Xu K
    Front Mol Biosci; 2022; 9():947208. PubMed ID: 36052168
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Li Y; Zhang J; Zhang K; Chen Y; Wang W; Chen H; Zou Z; Li Y; Dai M
    Front Oncol; 2022; 12():693395. PubMed ID: 35321425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CISD2 Promotes Resistance to Sorafenib-Induced Ferroptosis by Regulating Autophagy in Hepatocellular Carcinoma.
    Li B; Wei S; Yang L; Peng X; Ma Y; Wu B; Fan Q; Yang S; Li X; Jin H; Tang S; Huang M; Li H; Liu J
    Front Oncol; 2021; 11():657723. PubMed ID: 34485112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Insights in the Regulatory Mechanisms of Ferroptosis in Hepatocellular Carcinoma.
    Ma S; Adzavon YM; Wen X; Zhao P; Xie F; Liu M; Ma X
    Front Cell Dev Biol; 2022; 10():873029. PubMed ID: 35663406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of ferroptosis and its non-coding RNA regulation in hepatocellular carcinoma.
    Yang L; Guan Y; Liu Z
    Front Pharmacol; 2023; 14():1177405. PubMed ID: 37124203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iron accumulation and lipid peroxidation: implication of ferroptosis in hepatocellular carcinoma.
    Li X; Meng F; Wang H; Sun L; Chang S; Li G; Chen F
    Front Endocrinol (Lausanne); 2023; 14():1319969. PubMed ID: 38274225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ferroptosis in Hepatocellular Carcinoma: Mechanisms, Drug Targets and Approaches to Clinical Translation.
    Bekric D; Ocker M; Mayr C; Stintzing S; Ritter M; Kiesslich T; Neureiter D
    Cancers (Basel); 2022 Apr; 14(7):. PubMed ID: 35406596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncogenic Activation of YAP Signaling Sensitizes Ferroptosis of Hepatocellular Carcinoma
    Qin Y; Pei Z; Feng Z; Lin P; Wang S; Li Y; Huo F; Wang Q; Wang Z; Chen ZN; Wu J; Wang YF
    Front Cell Dev Biol; 2021; 9():751593. PubMed ID: 34977009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Ferroptosis in the Treatment and Drug Resistance of Hepatocellular Carcinoma.
    Zhao S; Zheng W; Yu C; Xu G; Zhang X; Pan C; Feng Y; Yang K; Zhou J; Ma Y
    Front Cell Dev Biol; 2022; 10():845232. PubMed ID: 35309918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sorafenib induces mitochondrial dysfunction and exhibits synergistic effect with cysteine depletion by promoting HCC cells ferroptosis.
    Li Y; Xia J; Shao F; Zhou Y; Yu J; Wu H; Du J; Ren X
    Biochem Biophys Res Commun; 2021 Jan; 534():877-884. PubMed ID: 33162029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting ferroptosis in hepatocellular carcinoma.
    Mo Y; Zou Z; Chen E
    Hepatol Int; 2024 Feb; 18(1):32-49. PubMed ID: 37880567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iron-dependent cell death of hepatocellular carcinoma cells exposed to sorafenib.
    Louandre C; Ezzoukhry Z; Godin C; Barbare JC; Mazière JC; Chauffert B; Galmiche A
    Int J Cancer; 2013 Oct; 133(7):1732-42. PubMed ID: 23505071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of sorafenib resistance associated with ferroptosis in HCC.
    Guo L; Hu C; Yao M; Han G
    Front Pharmacol; 2023; 14():1207496. PubMed ID: 37351514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haloperidol, a sigma receptor 1 antagonist, promotes ferroptosis in hepatocellular carcinoma cells.
    Bai T; Wang S; Zhao Y; Zhu R; Wang W; Sun Y
    Biochem Biophys Res Commun; 2017 Sep; 491(4):919-925. PubMed ID: 28756230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells.
    Sun X; Ou Z; Chen R; Niu X; Chen D; Kang R; Tang D
    Hepatology; 2016 Jan; 63(1):173-84. PubMed ID: 26403645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ferroptosis: a new promising target for hepatocellular carcinoma therapy.
    Xu Q; Ren L; Ren N; Yang Y; Pan J; Zheng Y; Wang G
    Mol Cell Biochem; 2023 Dec; ():. PubMed ID: 38051404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Critical Role of Ferroptosis in Hepatocellular Carcinoma.
    Pan F; Lin X; Hao L; Wang T; Song H; Wang R
    Front Cell Dev Biol; 2022; 10():882571. PubMed ID: 35800895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.